- Home
- LSEA vs AMRN Comparison
LSEA vs AMRN Comparison
Compare LSEA & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSEA
- AMRN
- Stock Information
- Founded
- LSEA 2013
- AMRN 1989
- Country
- LSEA United States
- AMRN Ireland
- Employees
- LSEA N/A
- AMRN N/A
- Industry
- LSEA Homebuilding
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- LSEA Consumer Discretionary
- AMRN Health Care
- Exchange
- LSEA Nasdaq
- AMRN Nasdaq
- Market Cap
- LSEA 222.1M
- AMRN 216.0M
- IPO Year
- LSEA N/A
- AMRN 1993
- Fundamental
- Price
- LSEA $6.77
- AMRN $11.06
- Analyst Decision
- LSEA Buy
- AMRN Sell
- Analyst Count
- LSEA 4
- AMRN 2
- Target Price
- LSEA $13.50
- AMRN $7.00
- AVG Volume (30 Days)
- LSEA 200.4K
- AMRN 117.9K
- Earning Date
- LSEA 05-12-2025
- AMRN 05-07-2025
- Dividend Yield
- LSEA N/A
- AMRN N/A
- EPS Growth
- LSEA N/A
- AMRN N/A
- EPS
- LSEA 0.47
- AMRN N/A
- Revenue
- LSEA $1,550,337,000.00
- AMRN $214,112,000.00
- Revenue This Year
- LSEA N/A
- AMRN N/A
- Revenue Next Year
- LSEA $3.52
- AMRN $0.89
- P/E Ratio
- LSEA $12.98
- AMRN N/A
- Revenue Growth
- LSEA 28.13
- AMRN N/A
- 52 Week Low
- LSEA $5.41
- AMRN $7.00
- 52 Week High
- LSEA $14.04
- AMRN $20.60
- Technical
- Relative Strength Index (RSI)
- LSEA 50.93
- AMRN 57.96
- Support Level
- LSEA $5.79
- AMRN $9.44
- Resistance Level
- LSEA $6.60
- AMRN $11.44
- Average True Range (ATR)
- LSEA 0.33
- AMRN 0.79
- MACD
- LSEA 0.05
- AMRN 0.01
- Stochastic Oscillator
- LSEA 53.09
- AMRN 63.11
About LSEA Landsea Homes Corporation
Landsea Homes Corp is a growth-oriented homebuilder focused on providing High-Performance Homes that deliver energy-efficient living in attractive geographies. It is engaged in the design, construction, marketing and sale of suburban and urban single-family detached and attached homes in Arizona, California, Colorado, Florida, Texas, and Metro New York. While It offers a wide range of housing options, it focuses on entry-level and first-time move-up homes and believes its markets are characterized by attractive long-term housing fundamentals. The company's segments include Arizona, California, Colorado, Florida, Metro New York, and Texas. It derives a majority of its revenue from home sales in Florida.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.